Description: Aflatoxin Q1 is a derivate of Aflatoxin B1. It is created in human body as a in-vivo detoxification process of Aflatoxin B1.
Solubility ( literature ): May be dissolved in DCM, DMSO or Methanol
Applications:
Composition: Ingredient type Fermentek product
Disclaimer: For Research use only, Not for Human or Drug use, Not extracted from humans or animals, Refer to MSDS for further safety and handling instructions
Names and identifiers: Synonyms Cyclopenta[c]furo[3',2':4,5]furo[2,3-h][1]benzopyran-1,11-dione, 2,3,6a,9a-tetrahydro-3-hydroxy-4-methoxy-, (3S,6aR,9aS)- 3-Hydroxy-4-methoxy-2,3,6a,9a-tetrahydrocyclopenta[c]furo[3',2':4,5]furo[2,3-h][1]benzopyran-1,11-dione IUPAC Name: (3S,6aR,9aS)-3-Hydroxy-4-methoxy-2,3,6a,9a-tetrahydrocyclopenta[c]furo[3',2':4,5]furo[2,3-h][1]benzopyran-1,11-dione RTECS GY1800000
Pub 1: J Microbiol Biotechnol 2020 Aug 28;30(8):1207-1213. Detoxification of Aflatoxin B1 Contaminated Maize Using Human CYP3A4 Marie Yamada Koji Hatsuta Mayuko Niikawa Hiromasa Imaishi Biochemistry and molecular biology international 43, 839-846 [PubMed:9385444] Differential inhibition of aflatoxin B1 oxidation by gestodene action on human liver microsomes. Kim BR, Oh HS, Kim DH (1997) Research communications in chemical pathology and pharmacology 50, 103-123 [PubMed:4081304] The in vitro metabolism of aflatoxin Q1 by mouse and rabbit liver preparations. Yourtee DM, Rohrig TP (1985)
Source: Synthetic
Chemical name:
InChl Key: GYNOTJLCULOEIM-XKRJZGAWSA-N